[123i] Sodium Iodide Injection Ge Healthcare

Sodium Iodide (123 I) Injection is a radiopharmaceutical used for diagnostic imaging of thyroid function and structure. This sterile solution is administered intravenously for precise medical imaging. Short half-life minimizes radiation exposure. Suitable for nuclear medicine procedures.

Sodium Iodide (123 I) Injection is primarily used in nuclear medicine for diagnostic imaging of the thyroid gland. It helps evaluate thyroid function, detect abnormalities like nodules or hyperthyroidism, and assess post-treatment changes. The radiopharmaceutical is also used in whole-body scans to identify metastatic thyroid cancer. Commonly prescribed by healthcare providers for detailed thyroid assessment.

After intravenous administration, Sodium Iodide (123 I) is absorbed by the thyroid gland, emitting gamma radiation detectable by imaging equipment. This allows for clear visualization of thyroid tissue and function. The effects are temporary, with the radiopharmaceutical cleared from the body within hours. Patients may experience mild discomfort at the injection site.

Sodium Iodide (123 I) Injection should only be handled and administered by qualified healthcare professionals. Pregnant or breastfeeding individuals should avoid exposure due to potential risks to the fetus or infant. Patients with known iodine sensitivity or thyroid cancer undergoing treatment should inform their provider. Proper shielding and radiation safety protocols must be followed during use.

Certain medications, such as thyroid hormones, antithyroid drugs, or iodine-containing supplements, may interfere with the uptake of Sodium Iodide (123 I). Patients should disclose all current medications to their healthcare provider. Contrast agents used in imaging may also affect results. Alcohol and specific dietary restrictions may be advised before the procedure.